Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Injectable Anticoagulants Market 2018, Forecast to 2023

Publisher Name :
Date: 11-Jul-2018
No. of pages: 137

The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]).

Scope of the Report:

This report focuses on the Injectable Anticoagulants in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow.

The classification of injectable anticoagulants includes LMWH, DTI and other, and the proportion of LMWH in 2016 is about 55%, and the proportion is in decreasing trend from 2012 to 2016.

Injectable anticoagulants are widely used for VTE, ACS/MI, AF and other field. The most proportion of injectable anticoagulants used to treat AF, and the revenue in 2016 is 3400 M USD.

The worldwide market for Injectable Anticoagulants is expected to grow at a CAGR of roughly 2.7% over the next five years, will reach 6440 million US$ in 2023, from 5490 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Sanofi

- Genentech (Roche)

- Boehringer Ingelheim

- Pfizer

- The Medicines Company

- Aspen

- Otsuka

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Low-molecular-weight Heparin (LMWH)

- Direct Thrombin Inhibitor (DTI)

- Other

Market Segment by Applications, can be divided into

- VTE

- ACS/MI

- AF

- Other

There are 15 Chapters to deeply display the global Injectable Anticoagulants market.

Chapter 1, to describe Injectable Anticoagulants Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Injectable Anticoagulants, with sales, revenue, and price of Injectable Anticoagulants, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Injectable Anticoagulants, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Injectable Anticoagulants market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Injectable Anticoagulants sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Injectable Anticoagulants Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Injectable Anticoagulants Introduction
1.2 Market Analysis by Type
1.2.1 Low-molecular-weight Heparin (LMWH)
1.2.2 Direct Thrombin Inhibitor (DTI)
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 VTE
1.3.2 ACS/MI
1.3.3 AF
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.1.1 Sanofi Description
2.1.1.2 Sanofi Headquarter, Main Business and Finance Overview
2.1.2 Sanofi Injectable Anticoagulants Product Introduction
2.1.2.1 Injectable Anticoagulants Production Bases, Sales Regions and Major Competitors
2.1.2.2 Injectable Anticoagulants Product Information
2.1.3 Sanofi Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Sanofi Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Sanofi Injectable Anticoagulants Market Share in 2017
2.2 Genentech (Roche)
2.2.1 Business Overview
2.2.1.1 Genentech (Roche) Description
2.2.1.2 Genentech (Roche) Headquarter, Main Business and Finance Overview
2.2.2 Genentech (Roche) Injectable Anticoagulants Product Introduction
2.2.2.1 Injectable Anticoagulants Production Bases, Sales Regions and Major Competitors
2.2.2.2 Injectable Anticoagulants Product Information
2.2.3 Genentech (Roche) Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Genentech (Roche) Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Genentech (Roche) Injectable Anticoagulants Market Share in 2017
2.3 Boehringer Ingelheim
2.3.1 Business Overview
2.3.1.1 Boehringer Ingelheim Description
2.3.1.2 Boehringer Ingelheim Headquarter, Main Business and Finance Overview
2.3.2 Boehringer Ingelheim Injectable Anticoagulants Product Introduction
2.3.2.1 Injectable Anticoagulants Production Bases, Sales Regions and Major Competitors
2.3.2.2 Injectable Anticoagulants Product Information
2.3.3 Boehringer Ingelheim Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Boehringer Ingelheim Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Boehringer Ingelheim Injectable Anticoagulants Market Share in 2017
2.4 Pfizer
2.4.1 Business Overview
2.4.1.1 Pfizer Description
2.4.1.2 Pfizer Headquarter, Main Business and Finance Overview
2.4.2 Pfizer Injectable Anticoagulants Product Introduction
2.4.2.1 Injectable Anticoagulants Production Bases, Sales Regions and Major Competitors
2.4.2.2 Injectable Anticoagulants Product Information
2.4.3 Pfizer Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Pfizer Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Pfizer Injectable Anticoagulants Market Share in 2017
2.5 The Medicines Company
2.5.1 Business Overview
2.5.1.1 The Medicines Company Description
2.5.1.2 The Medicines Company Headquarter, Main Business and Finance Overview
2.5.2 The Medicines Company Injectable Anticoagulants Product Introduction
2.5.2.1 Injectable Anticoagulants Production Bases, Sales Regions and Major Competitors
2.5.2.2 Injectable Anticoagulants Product Information
2.5.3 The Medicines Company Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 The Medicines Company Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global The Medicines Company Injectable Anticoagulants Market Share in 2017
2.6 Aspen
2.6.1 Business Overview
2.6.1.1 Aspen Description
2.6.1.2 Aspen Headquarter, Main Business and Finance Overview
2.6.2 Aspen Injectable Anticoagulants Product Introduction
2.6.2.1 Injectable Anticoagulants Production Bases, Sales Regions and Major Competitors
2.6.2.2 Injectable Anticoagulants Product Information
2.6.3 Aspen Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Aspen Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Aspen Injectable Anticoagulants Market Share in 2017
2.7 Otsuka
2.7.1 Business Overview
2.7.1.1 Otsuka Description
2.7.1.2 Otsuka Headquarter, Main Business and Finance Overview
2.7.2 Otsuka Injectable Anticoagulants Product Introduction
2.7.2.1 Injectable Anticoagulants Production Bases, Sales Regions and Major Competitors
2.7.2.2 Injectable Anticoagulants Product Information
2.7.3 Otsuka Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Otsuka Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Otsuka Injectable Anticoagulants Market Share in 2017
3 Global Injectable Anticoagulants Market Competition, by Manufacturer
3.1 Global Injectable Anticoagulants Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Injectable Anticoagulants Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Injectable Anticoagulants Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Injectable Anticoagulants Manufacturer Market Share in 2017
3.4.2 Top 5 Injectable Anticoagulants Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Injectable Anticoagulants Market Analysis by Regions
4.1 Global Injectable Anticoagulants Sales, Revenue and Market Share by Regions
4.1.1 Global Injectable Anticoagulants Sales by Regions (2013-2018)
4.1.2 Global Injectable Anticoagulants Revenue by Regions (2013-2018)
4.2 North America Injectable Anticoagulants Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Injectable Anticoagulants Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Injectable Anticoagulants Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Injectable Anticoagulants Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Injectable Anticoagulants Sales, Revenue and Growth Rate (2013-2018)
5 North America Injectable Anticoagulants by Countries, Type, Application and Manufacturers
5.1 North America Injectable Anticoagulants Sales, Revenue and Market Share by Countries
5.1.1 North America Injectable Anticoagulants Sales by Countries (2013-2018)
5.1.2 North America Injectable Anticoagulants Revenue by Countries (2013-2018)
5.1.3 United States Injectable Anticoagulants Sales and Growth Rate (2013-2018)
5.1.4 Canada Injectable Anticoagulants Sales and Growth Rate (2013-2018)
5.1.5 Mexico Injectable Anticoagulants Sales and Growth Rate (2013-2018)
5.2 North America Injectable Anticoagulants Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Injectable Anticoagulants Sales by Manufacturers (2016-2017)
5.2.2 North America Injectable Anticoagulants Revenue by Manufacturers (2016-2017)
5.3 North America Injectable Anticoagulants Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Injectable Anticoagulants Sales and Sales Share by Type (2013-2018)
5.3.2 North America Injectable Anticoagulants Revenue and Revenue Share by Type (2013-2018)
5.4 North America Injectable Anticoagulants Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Injectable Anticoagulants Sales and Sales Share by Application (2013-2018)
5.4.2 North America Injectable Anticoagulants Revenue and Revenue Share by Application (2013-2018)
6 Europe Injectable Anticoagulants by Countries, Type, Application and Manufacturers
6.1 Europe Injectable Anticoagulants Sales, Revenue and Market Share by Countries
6.1.1 Europe Injectable Anticoagulants Sales by Countries (2013-2018)
6.1.2 Europe Injectable Anticoagulants Revenue by Countries (2013-2018)
6.1.3 Germany Injectable Anticoagulants Sales and Growth Rate (2013-2018)
6.1.4 UK Injectable Anticoagulants Sales and Growth Rate (2013-2018)
6.1.5 France Injectable Anticoagulants Sales and Growth Rate (2013-2018)
6.1.6 Russia Injectable Anticoagulants Sales and Growth Rate (2013-2018)
6.1.7 Italy Injectable Anticoagulants Sales and Growth Rate (2013-2018)
6.2 Europe Injectable Anticoagulants Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Injectable Anticoagulants Sales by Manufacturers (2016-2017)
6.2.2 Europe Injectable Anticoagulants Revenue by Manufacturers (2016-2017)
6.3 Europe Injectable Anticoagulants Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Injectable Anticoagulants Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Injectable Anticoagulants Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Injectable Anticoagulants Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Injectable Anticoagulants Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Injectable Anticoagulants Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Injectable Anticoagulants by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Injectable Anticoagulants Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Injectable Anticoagulants Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Injectable Anticoagulants Revenue by Countries (2013-2018)
7.1.3 China Injectable Anticoagulants Sales and Growth Rate (2013-2018)
7.1.4 Japan Injectable Anticoagulants Sales and Growth Rate (2013-2018)
7.1.5 Korea Injectable Anticoagulants Sales and Growth Rate (2013-2018)
7.1.6 India Injectable Anticoagulants Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Injectable Anticoagulants Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Injectable Anticoagulants Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Injectable Anticoagulants Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Injectable Anticoagulants Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Injectable Anticoagulants Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Injectable Anticoagulants Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Injectable Anticoagulants Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Injectable Anticoagulants Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Injectable Anticoagulants Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Injectable Anticoagulants Revenue and Revenue Share by Application (2013-2018)
8 South America Injectable Anticoagulants by Countries, Type, Application and Manufacturers
8.1 South America Injectable Anticoagulants Sales, Revenue and Market Share by Countries
8.1.1 South America Injectable Anticoagulants Sales by Countries (2013-2018)
8.1.2 South America Injectable Anticoagulants Revenue by Countries (2013-2018)
8.1.3 Brazil Injectable Anticoagulants Sales and Growth Rate (2013-2018)
8.1.4 Argentina Injectable Anticoagulants Sales and Growth Rate (2013-2018)
8.1.5 Colombia Injectable Anticoagulants Sales and Growth Rate (2013-2018)
8.2 South America Injectable Anticoagulants Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Injectable Anticoagulants Sales by Manufacturers (2016-2017)
8.2.2 South America Injectable Anticoagulants Revenue by Manufacturers (2016-2017)
8.3 South America Injectable Anticoagulants Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Injectable Anticoagulants Sales and Sales Share by Type (2013-2018)
8.3.2 South America Injectable Anticoagulants Revenue and Revenue Share by Type (2013-2018)
8.4 South America Injectable Anticoagulants Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Injectable Anticoagulants Sales and Sales Share by Application (2013-2018)
8.4.2 South America Injectable Anticoagulants Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Injectable Anticoagulants by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Injectable Anticoagulants Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Injectable Anticoagulants Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Injectable Anticoagulants Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Injectable Anticoagulants Sales and Growth Rate (2013-2018)
9.1.4 UAE Injectable Anticoagulants Sales and Growth Rate (2013-2018)
9.1.5 Egypt Injectable Anticoagulants Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Injectable Anticoagulants Sales and Growth Rate (2013-2018)
9.1.7 South Africa Injectable Anticoagulants Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Injectable Anticoagulants Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Injectable Anticoagulants Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Injectable Anticoagulants Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Injectable Anticoagulants Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Injectable Anticoagulants Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Injectable Anticoagulants Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Injectable Anticoagulants Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Injectable Anticoagulants Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Injectable Anticoagulants Revenue and Revenue Share by Application (2013-2018)
10 Global Injectable Anticoagulants Market Segment by Type
10.1 Global Injectable Anticoagulants Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Injectable Anticoagulants Sales and Market Share by Type (2013-2018)
10.1.2 Global Injectable Anticoagulants Revenue and Market Share by Type (2013-2018)
10.2 Low-molecular-weight Heparin (LMWH) Sales Growth and Price
10.2.1 Global Low-molecular-weight Heparin (LMWH) Sales Growth (2013-2018)
10.2.2 Global Low-molecular-weight Heparin (LMWH) Price (2013-2018)
10.3 Direct Thrombin Inhibitor (DTI) Sales Growth and Price
10.3.1 Global Direct Thrombin Inhibitor (DTI) Sales Growth (2013-2018)
10.3.2 Global Direct Thrombin Inhibitor (DTI) Price (2013-2018)
10.4 Other Sales Growth and Price
10.4.1 Global Other Sales Growth (2013-2018)
10.4.2 Global Other Price (2013-2018)
11 Global Injectable Anticoagulants Market Segment by Application
11.1 Global Injectable Anticoagulants Sales Market Share by Application (2013-2018)
11.2 VTE Sales Growth (2013-2018)
11.3 ACS/MI Sales Growth (2013-2018)
11.4 AF Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Injectable Anticoagulants Market Forecast (2018-2023)
12.1 Global Injectable Anticoagulants Sales, Revenue and Growth Rate (2018-2023)
12.2 Injectable Anticoagulants Market Forecast by Regions (2018-2023)
12.2.1 North America Injectable Anticoagulants Market Forecast (2018-2023)
12.2.2 Europe Injectable Anticoagulants Market Forecast (2018-2023)
12.2.3 Asia-Pacific Injectable Anticoagulants Market Forecast (2018-2023)
12.2.4 South America Injectable Anticoagulants Market Forecast (2018-2023)
12.2.5 Middle East and Africa Injectable Anticoagulants Market Forecast (2018-2023)
12.3 Injectable Anticoagulants Market Forecast by Type (2018-2023)
12.3.1 Global Injectable Anticoagulants Sales Forecast by Type (2018-2023)
12.3.2 Global Injectable Anticoagulants Market Share Forecast by Type (2018-2023)
12.4 Injectable Anticoagulants Market Forecast by Application (2018-2023)
12.4.1 Global Injectable Anticoagulants Sales Forecast by Application (2018-2023)
12.4.2 Global Injectable Anticoagulants Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Injectable Anticoagulants Picture
Table Product Specifications of Injectable Anticoagulants
Figure Global Injectable Anticoagulants CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Injectable Anticoagulants CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Injectable Anticoagulants by Types in 2017
Figure Low-molecular-weight Heparin (LMWH) Picture
Table Major Manufacturers of Low-molecular-weight Heparin (LMWH)
Figure Direct Thrombin Inhibitor (DTI) Picture
Table Major Manufacturers of Direct Thrombin Inhibitor (DTI)
Figure Other Picture
Table Major Manufacturers of Other
Figure Injectable Anticoagulants Sales Market Share by Applications in 2017
Figure VTE Picture
Figure ACS/MI Picture
Figure AF Picture
Figure Other Picture
Figure United States Injectable Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Injectable Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Injectable Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Injectable Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure France Injectable Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure UK Injectable Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Injectable Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Injectable Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure China Injectable Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Injectable Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Injectable Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure India Injectable Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Injectable Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Injectable Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Injectable Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Injectable Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Injectable Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Injectable Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Table Sanofi Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi Injectable Anticoagulants Production Bases, Sales Regions and Major Competitors
Table Sanofi Injectable Anticoagulants Product
Table Sanofi Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi Injectable Anticoagulants Sales Market Share in 2017
Figure Global Sanofi Injectable Anticoagulants Revenue Market Share in 2017
Table Genentech (Roche) Headquarter, Established, Main Business and Finance Overview (2017)
Table Genentech (Roche) Injectable Anticoagulants Production Bases, Sales Regions and Major Competitors
Table Genentech (Roche) Injectable Anticoagulants Product
Table Genentech (Roche) Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Genentech (Roche) Injectable Anticoagulants Sales Market Share in 2017
Figure Global Genentech (Roche) Injectable Anticoagulants Revenue Market Share in 2017
Table Boehringer Ingelheim Headquarter, Established, Main Business and Finance Overview (2017)
Table Boehringer Ingelheim Injectable Anticoagulants Production Bases, Sales Regions and Major Competitors
Table Boehringer Ingelheim Injectable Anticoagulants Product
Table Boehringer Ingelheim Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Boehringer Ingelheim Injectable Anticoagulants Sales Market Share in 2017
Figure Global Boehringer Ingelheim Injectable Anticoagulants Revenue Market Share in 2017
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Injectable Anticoagulants Production Bases, Sales Regions and Major Competitors
Table Pfizer Injectable Anticoagulants Product
Table Pfizer Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Injectable Anticoagulants Sales Market Share in 2017
Figure Global Pfizer Injectable Anticoagulants Revenue Market Share in 2017
Table The Medicines Company Headquarter, Established, Main Business and Finance Overview (2017)
Table The Medicines Company Injectable Anticoagulants Production Bases, Sales Regions and Major Competitors
Table The Medicines Company Injectable Anticoagulants Product
Table The Medicines Company Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global The Medicines Company Injectable Anticoagulants Sales Market Share in 2017
Figure Global The Medicines Company Injectable Anticoagulants Revenue Market Share in 2017
Table Aspen Headquarter, Established, Main Business and Finance Overview (2017)
Table Aspen Injectable Anticoagulants Production Bases, Sales Regions and Major Competitors
Table Aspen Injectable Anticoagulants Product
Table Aspen Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Aspen Injectable Anticoagulants Sales Market Share in 2017
Figure Global Aspen Injectable Anticoagulants Revenue Market Share in 2017
Table Otsuka Headquarter, Established, Main Business and Finance Overview (2017)
Table Otsuka Injectable Anticoagulants Production Bases, Sales Regions and Major Competitors
Table Otsuka Injectable Anticoagulants Product
Table Otsuka Injectable Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Otsuka Injectable Anticoagulants Sales Market Share in 2017
Figure Global Otsuka Injectable Anticoagulants Revenue Market Share in 2017
Table Global Injectable Anticoagulants Sales by Manufacturer (2016-2017)
Figure Global Injectable Anticoagulants Sales Market Share by Manufacturer in 2016
Figure Global Injectable Anticoagulants Sales Market Share by Manufacturer in 2017
Table Global Injectable Anticoagulants Revenue by Manufacturer (2016-2017)
Figure Global Injectable Anticoagulants Revenue Market Share by Manufacturer in 2016
Figure Global Injectable Anticoagulants Revenue Market Share by Manufacturer in 2017
Table Global Injectable Anticoagulants Price by Manufacturer (2016-2017)
Figure Top 3 Injectable Anticoagulants Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Injectable Anticoagulants Manufacturer (Revenue) Market Share in 2017
Figure Global Injectable Anticoagulants Sales and Growth Rate (2013-2018)
Figure Global Injectable Anticoagulants Revenue and Growth Rate (2013-2018)
Table Global Injectable Anticoagulants Sales by Regions (2013-2018)
Table Global Injectable Anticoagulants Sales Market Share by Regions (2013-2018)
Table Global Injectable Anticoagulants Revenue by Regions (2013-2018)
Figure Global Injectable Anticoagulants Revenue Market Share by Regions in 2013
Figure Global Injectable Anticoagulants Revenue Market Share by Regions in 2017
Figure North America Injectable Anticoagulants Sales and Growth Rate (2013-2018)
Figure North America Injectable Anticoagulants Revenue and Growth Rate (2013-2018)
Figure Europe Injectable Anticoagulants Sales and Growth Rate (2013-2018)
Figure Europe Injectable Anticoagulants Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Injectable Anticoagulants Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Injectable Anticoagulants Revenue and Growth Rate (2013-2018)
Figure South America Injectable Anticoagulants Sales and Growth Rate (2013-2018)
Figure South America Injectable Anticoagulants Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Injectable Anticoagulants Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Injectable Anticoagulants Revenue and Growth Rate (2013-2018)
Figure North America Injectable Anticoagulants Revenue and Growth Rate (2013-2018)
Table North America Injectable Anticoagulants Sales by Countries (2013-2018)
Table North America Injectable Anticoagulants Sales Market Share by Countries (2013-2018)
Figure North America Injectable Anticoagulants Sales Market Share by Countries in 2013
Figure North America Injectable Anticoagulants Sales Market Share by Countries in 2017
Table North America Injectable Anticoagulants Revenue by Countries (2013-2018)
Table North America Injectable Anticoagulants Revenue Market Share by Countries (2013-2018)
Figure North America Injectable Anticoagulants Revenue Market Share by Countries in 2013
Figure North America Injectable Anticoagulants Revenue Market Share by Countries in 2017
Figure United States Injectable Anticoagulants Sales and Growth Rate (2013-2018)
Figure Canada Injectable Anticoagulants Sales and Growth Rate (2013-2018)
Figure Mexico Injectable Anticoagulants Sales and Growth Rate (2013-2018)
Table North America Injectable Anticoagulants Sales by Manufacturer (2016-2017)
Figure North America Injectable Anticoagulants Sales Market Share by Manufacturer in 2016
Figure North America Injectable Anticoagulants Sales Market Share by Manufacturer in 2017
Table North America Injectable Anticoagulants Revenue by Manufacturer (2016-2017)
Figure North America Injectable Anticoagulants Revenue Market Share by Manufacturer in 2016
Figure North America Injectable Anticoagulants Revenue Market Share by Manufacturer in 2017
Table North America Injectable Anticoagulants Sales by Type (2013-2018)
Table North America Injectable Anticoagulants Sales Share by Type (2013-2018)
Table North America Injectable Anticoagulants Revenue by Type (2013-2018)
Table North America Injectable Anticoagulants Revenue Share by Type (2013-2018)
Table North America Injectable Anticoagulants Sales by Application (2013-2018)
Table North America Injectable Anticoagulants Sales Share by Application (2013-2018)
Table North America Injectable Anticoagulants Revenue by Application (2013-2018)
Table North America Injectable Anticoagulants Revenue Share by Application (2013-2018)
Figure Europe Injectable Anticoagulants Revenue and Growth Rate (2013-2018)
Table Europe Injectable Anticoagulants Sales by Countries (2013-2018)
Table Europe Injectable Anticoagulants Sales Market Share by Countries (2013-2018)
Table Europe Injectable Anticoagulants Revenue by Countries (2013-2018)
Figure Europe Injectable Anticoagulants Revenue Market Share by Countries in 2016
Figure Europe Injectable Anticoagulants Revenue Market Share by Countries in 2017
Figure Germany Injectable Anticoagulants Sales and Growth Rate (2013-2018)
Figure UK Injectable Anticoagulants Sales and Growth Rate (2013-2018)
Figure France Injectable Anticoagulants Sales and Growth Rate (2013-2018)
Figure Russia Injectable Anticoagulants Sales and Growth Rate (2013-2018)
Figure Italy Injectable Anticoagulants Sales and Growth Rate (2013-2018)
Table Europe Injectable Anticoagulants Sales by Manufacturer (2016-2017)
Figure Europe Injectable Anticoagulants Sales Market Share by Manufacturer in 2016
Figure Europe Injectable Anticoagulants Sales Market Share by Manufacturer in 2017
Table Europe Injectable Anticoagulants Revenue by Manufacturer (2016-2017)
Figure Europe Injectable Anticoagulants Revenue Market Share by Manufacturer in 2016
Figure Europe Injectable Anticoagulants Revenue Market Share by Manufacturer in 2017
Table Europe Injectable Anticoagulants Sales by Type (2013-2018)
Table Europe Injectable Anticoagulants Sales Share by Type (2013-2018)
Table Europe Injectable Anticoagulants Revenue by Type (2013-2018)
Table Europe Injectable Anticoagulants Revenue Share by Type (2013-2018)
Table Europe Injectable Anticoagulants Sales by Application (2013-2018)
Table Europe Injectable Anticoagulants Sales Share by Application (2013-2018)
Table Europe Injectable Anticoagulants Revenue by Application (2013-2018)
Table Europe Injectable Anticoagulants Revenue Share by Application (2013-2018)
Figure Asia-Pacific Injectable Anticoagulants Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Injectable Anticoagulants Sales by Countries (2013-2018)
Table Asia-Pacific Injectable Anticoagulants Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Injectable Anticoagulants Sales Market Share by Countries 2017
Table Asia-Pacific Injectable Anticoagulants Revenue by Countries (2013-2018)
Figure Asia-Pacific Injectable Anticoagulants Revenue Market Share by Countries 2017
Figure China Injectable Anticoagulants Sales and Growth Rate (2013-2018)
Figure Japan Injectable Anticoagulants Sales and Growth Rate (2013-2018)
Figure Korea Injectable Anticoagulants Sales and Growth Rate (2013-2018)
Figure India Injectable Anticoagulants Sales and Growth Rate (2013-2018)
Figure Southeast Asia Injectable Anticoagulants Sales and Growth Rate (2013-2018)
Table Asia-Pacific Injectable Anticoagulants Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Injectable Anticoagulants Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Injectable A
  • 2018-2023 Global Injectable Anticoagulants Consumption Market Report
    Published: 12-Jul-2018        Price: US 4660 Onwards        Pages: 139
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Injectable Anticoagulants market for 2018-2023. The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]). In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectabl......
  • 2018 Top 5 Injectable Anticoagulants Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 12-Jul-2018        Price: US 4960 Onwards        Pages: 125
    The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]). In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow. The classification of injectable anticoagulants includes LMWH, DTI and other, and the proportion of LMWH in......
  • 2018-2023 Global Anticoagulants Consumption Market Report
    Published: 12-Jul-2018        Price: US 4660 Onwards        Pages: 162
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Anticoagulants market for 2018-2023. Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some bloo......
  • 2018 Top 5 Anticoagulants Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 12-Jul-2018        Price: US 4960 Onwards        Pages: 143
    Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various......
  • Global Anticoagulants Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 11-Jul-2018        Price: US 3480 Onwards        Pages: 132
    Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Anticoagulants Market 2018, Forecast to 2023
    Published: 11-Jul-2018        Price: US 4880 Onwards        Pages: 132
    Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various......
  • Global Injectable Anticoagulants Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 11-Jul-2018        Price: US 3480 Onwards        Pages: 128
    The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]). Scope of the Report: This report focuses on the Injectable Anticoagulants in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. In the last seve......
  • 2018-2023 India Heparin Market Report (Status and Outlook)
    Published: 05-Jul-2018        Price: US 3360 Onwards        Pages: 81
    In 2017, the Heparin market size was xx million USD in India, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In India market, the top players include - Hepalink - Changshan Pharm - Qianhong Bio-pharma - Opocrin - Pfizer - Aspen Oss - King-friend Biochemical Pharmaceutical - Bioibérica - Dongcheng Biochemicals - Jiulong Biochemicals - Tiandong - Xinbai - Yino......
  • 2018-2023 Philippines Heparin Market Report (Status and Outlook)
    Published: 05-Jul-2018        Price: US 3360 Onwards        Pages: 81
    In 2017, the Heparin market size was xx million USD in Philippines, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In Philippines market, the top players include - Hepalink - Changshan Pharm - Qianhong Bio-pharma - Opocrin - Pfizer - Aspen Oss - King-friend Biochemical Pharmaceutical - Bioibérica - Dongcheng Biochemicals - Jiulong Biochemicals - Tiandong - Xinbai......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs